• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醋酸环丙孕酮治疗重度多毛症的临床疗效与安全性:一项加拿大多中心研究的结果

Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study.

作者信息

Belisle S, Love E J

出版信息

Fertil Steril. 1986 Dec;46(6):1015-20.

PMID:2946604
Abstract

We compared the efficacy and safety of cyproterone acetate (Shering AC, Berlin, FRG) at a low (Diane, 2 mg) or a high dose (Androcur, 100 mg) in the treatment of 158 patients with severe hirsutism. At baseline, no difference was observed in mean hirsutism total index (19.5 Diane versus 20.1 Androcur) or distribution (facial, bust, or abdomen). By the end of the study, patient loss in Diane and Androcur groups was 29.1% and 27.8%, respectively, and the mean percent difference in the scoring index was as follows: total, 24.6 Diane versus 30.8 Androcur, P less than 0.05; facial, 30.1 Diane versus 33.0 Androcur, P less than 0.10; bust, 12.1 Diane versus 31.2 Androcur, P less than 0.02; and abdomen, 20.1 Diane versus 31.2 Androcur, P less than 0.02. Except for breast tenderness (Diane greater than Androcur), amenorrhea, and weight gain, (Androcur greater than Diane), the incidence of side effects was comparable in both groups.

摘要

我们比较了低剂量(达英,2毫克)和高剂量(环丙孕酮,100毫克)醋酸环丙孕酮(德国柏林先灵公司生产)治疗158例重度多毛症患者的疗效和安全性。基线时,多毛症总指数平均值(达英为19.5,环丙孕酮为20.1)或分布(面部、胸部或腹部)无差异。研究结束时,达英组和环丙孕酮组的患者流失率分别为29.1%和27.8%,评分指数的平均百分比差异如下:总体,达英为24.6,环丙孕酮为30.8,P<0.05;面部,达英为30.1,环丙孕酮为33.0,P<0.10;胸部,达英为12.1,环丙孕酮为31.2,P<0.02;腹部,达英为20.1,环丙孕酮为31.2,P<0.02。除乳房压痛(达英组高于环丙孕酮组)、闭经和体重增加(环丙孕酮组高于达英组)外,两组副作用发生率相当。

相似文献

1
Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study.醋酸环丙孕酮治疗重度多毛症的临床疗效与安全性:一项加拿大多中心研究的结果
Fertil Steril. 1986 Dec;46(6):1015-20.
2
[Treatment of moderately severe virilism of women with Diane and Androcur 10].[使用达英和环丙孕酮治疗女性中度严重男性化]
Z Hautkr. 1983 May 15;58(10):761-7.
3
[Anti-androgen treatment of hirsutism with cyproterone acetate].
Z Hautkr. 1990 Dec;65(12):1112-4.
4
[A new ovulation inhibitor antiandrogen].一种新型排卵抑制剂抗雄激素
J Bras Ginecol. 1984 Mar;94(3):91-7.
5
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.低剂量雌激素 - 抗雄激素联合用药(达英 - 35)对多囊卵巢综合征患者雄激素化临床体征、激素水平及卵巢大小的影响
Gynecol Endocrinol. 1989 Dec;3(4):269-80. doi: 10.3109/09513598909152466.
6
Cyproterone acetate as initial treatment and maintenance therapy for hirsutism.醋酸环丙孕酮作为多毛症的初始治疗和维持疗法。
Acta Endocrinol (Copenh). 1985 Aug;109(4):522-9. doi: 10.1530/acta.0.1090522.
7
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Fertil Steril. 2001 Mar;75(3):496-500. doi: 10.1016/s0015-0282(00)01764-7.
8
Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.醋酸环丙孕酮治疗重度多毛症:一项双盲剂量范围研究的结果
Clin Endocrinol (Oxf). 1991 Jul;35(1):5-10. doi: 10.1111/j.1365-2265.1991.tb03489.x.
9
A role for a non-androgenic anovulant in the management of hirsutism.
Ir J Med Sci. 1991 Jul;160(7):194-6. doi: 10.1007/BF02957310.
10
[Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
Fortschr Med. 1986 Jul 24;104(27-28):547-50.

引用本文的文献

1
Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential.天然化合物在多囊卵巢综合征管理中的应用:激素调节与治疗潜力的全面综述
Front Nutr. 2025 Feb 11;12:1520695. doi: 10.3389/fnut.2025.1520695. eCollection 2025.
2
Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.印度多囊卵巢综合征女性口服避孕药使用的共识声明。
J Hum Reprod Sci. 2018 Apr-Jun;11(2):96-118. doi: 10.4103/jhrs.JHRS_72_18.
3
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
多毛症的干预措施(不包括单独的激光和光脱毛治疗)。
Cochrane Database Syst Rev. 2015 Apr 28;2015(4):CD010334. doi: 10.1002/14651858.CD010334.pub2.
4
Cyproterone acetate for hirsutism.醋酸环丙孕酮治疗多毛症。
Cochrane Database Syst Rev. 2003;2003(4):CD001125. doi: 10.1002/14651858.CD001125.
5
A risk-benefit assessment of pharmacological therapies for hirsutism.多毛症药物治疗的风险效益评估。
Drug Saf. 2001;24(4):267-76. doi: 10.2165/00002018-200124040-00004.
6
Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
J Endocrinol Invest. 1999 Mar;22(3):165-8. doi: 10.1007/BF03343536.
7
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?多囊卵巢综合征患者单独使用抗雄激素治疗的实际效果如何?
J Endocrinol Invest. 1998 Oct;21(9):623-9. doi: 10.1007/BF03350788.
8
Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.醋酸环丙孕酮加炔雌醇与非那雄胺治疗多毛症的比较。
J Endocrinol Invest. 1998 Jun;21(6):348-52. doi: 10.1007/BF03350769.
9
A practical guide to the diagnosis and management of amenorrhoea.闭经诊断与管理实用指南
Drugs. 1996 Nov;52(5):671-81. doi: 10.2165/00003495-199652050-00005.